BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 28964257)

  • 1. The contribution of the acute phase response to the pathogenesis of relapse in chronic-relapsing experimental autoimmune encephalitis models of multiple sclerosis.
    Mardiguian S; Ladds E; Turner R; Shepherd H; Campbell SJ; Anthony DC
    J Neuroinflammation; 2017 Sep; 14(1):196. PubMed ID: 28964257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine production profiles in chronic relapsing-remitting experimental autoimmune encephalomyelitis: IFN-γ and TNF-α are important participants in the first attack but not in the relapse.
    Hidaka Y; Inaba Y; Matsuda K; Itoh M; Kaneyama T; Nakazawa Y; Koh CS; Ichikawa M
    J Neurol Sci; 2014 May; 340(1-2):117-22. PubMed ID: 24655735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RGS10 deficiency ameliorates the severity of disease in experimental autoimmune encephalomyelitis.
    Lee JK; Kannarkat GT; Chung J; Joon Lee H; Graham KL; Tansey MG
    J Neuroinflammation; 2016 Feb; 13():24. PubMed ID: 26831924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rescue from acute neuroinflammation by pharmacological chemokine-mediated deviation of leukocytes.
    Berghmans N; Heremans H; Li S; Martens E; Matthys P; Sorokin L; Van Damme J; Opdenakker G
    J Neuroinflammation; 2012 Oct; 9():243. PubMed ID: 23095573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental Autoimmune Encephalomyelitis (EAE) Model of Cynomolgus Macaques Induced by Recombinant Human MOG1-125 (rhMOG1-125) Protein and MOG34-56 Peptide.
    Peng Z; Zhang L; Wang H; He X; Peng X; Zhang Q; Liu H; Rao J; Wang H; Wu J; Sun Y
    Protein Pept Lett; 2018 Feb; 24(12):1166-1178. PubMed ID: 29141529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of cuprizone and experimental autoimmune encephalomyelitis to study inflammatory brain lesion formation and progression.
    Rüther BJ; Scheld M; Dreymueller D; Clarner T; Kress E; Brandenburg LO; Swartenbroekx T; Hoornaert C; Ponsaerts P; Fallier-Becker P; Beyer C; Rohr SO; Schmitz C; Chrzanowski U; Hochstrasser T; Nyamoya S; Kipp M
    Glia; 2017 Dec; 65(12):1900-1913. PubMed ID: 28836302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphodiesterase 5 inhibition at disease onset prevents experimental autoimmune encephalomyelitis progression through immunoregulatory and neuroprotective actions.
    Pifarré P; Gutierrez-Mecinas M; Prado J; Usero L; Roura-Mir C; Giralt M; Hidalgo J; García A
    Exp Neurol; 2014 Jan; 251():58-71. PubMed ID: 24211383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
    Zheng H; Zhang H; Liu F; Qi Y; Jiang H
    Immunol Lett; 2014; 157(1-2):38-44. PubMed ID: 24220208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory role of oligodendrocyte gap junctions in inflammatory demyelination.
    Papaneophytou CP; Georgiou E; Karaiskos C; Sargiannidou I; Markoullis K; Freidin MM; Abrams CK; Kleopa KA
    Glia; 2018 Dec; 66(12):2589-2603. PubMed ID: 30325069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nogo receptor complex expression dynamics in the inflammatory foci of central nervous system experimental autoimmune demyelination.
    Theotokis P; Touloumi O; Lagoudaki R; Nousiopoulou E; Kesidou E; Siafis S; Tselios T; Lourbopoulos A; Karacostas D; Grigoriadis N; Simeonidou C
    J Neuroinflammation; 2016 Oct; 13(1):265. PubMed ID: 27724971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-142 regulates inflammation and T cell differentiation in an animal model of multiple sclerosis.
    Talebi F; Ghorbani S; Chan WF; Boghozian R; Masoumi F; Ghasemi S; Vojgani M; Power C; Noorbakhsh F
    J Neuroinflammation; 2017 Mar; 14(1):55. PubMed ID: 28302134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune profile of an atypical EAE model in marmoset monkeys immunized with recombinant human myelin oligodendrocyte glycoprotein in incomplete Freund's adjuvant.
    Jagessar SA; Heijmans N; Blezer EL; Bauer J; Weissert R; 't Hart BA
    J Neuroinflammation; 2015 Sep; 12():169. PubMed ID: 26377397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of myelin peptide with vitamin D prevents autoimmune encephalomyelitis development.
    Mimura LA; Chiuso-Minicucci F; Fraga-Silva TF; Zorzella-Pezavento SF; França TG; Ishikawa LL; Penitenti M; Ikoma MR; Sartori A
    Neuroscience; 2016 Mar; 317():130-40. PubMed ID: 26762804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis.
    Gentile A; Musella A; Bullitta S; Fresegna D; De Vito F; Fantozzi R; Piras E; Gargano F; Borsellino G; Battistini L; Schubart A; Mandolesi G; Centonze D
    J Neuroinflammation; 2016 Aug; 13(1):207. PubMed ID: 27566665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in nociceptive sensitivity and object recognition in experimental autoimmune encephalomyelitis (EAE).
    Olechowski CJ; Tenorio G; Sauve Y; Kerr BJ
    Exp Neurol; 2013 Mar; 241():113-21. PubMed ID: 23291347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine and chemokine alterations in tissue, CSF, and plasma in early presymptomatic phase of experimental allergic encephalomyelitis (EAE), in a rat model of multiple sclerosis.
    Borjini N; Fernández M; Giardino L; Calzà L
    J Neuroinflammation; 2016 Nov; 13(1):291. PubMed ID: 27846891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of SOCS1 in macrophages in relapsing-remitting and chronic EAE and its role in disease severity.
    Berard JL; Kerr BJ; Johnson HM; David S
    Glia; 2010 Nov; 58(15):1816-26. PubMed ID: 20645407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic inactivation of the adenosine A(2A) receptor exacerbates brain damage in mice with experimental autoimmune encephalomyelitis.
    Yao SQ; Li ZZ; Huang QY; Li F; Wang ZW; Augusto E; He JC; Wang XT; Chen JF; Zheng RY
    J Neurochem; 2012 Oct; 123(1):100-12. PubMed ID: 22639925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin reduces experimental autoimmune encephalomyelitis severity via neuroprotective mechanisms.
    Moransard M; Bednar M; Frei K; Gassmann M; Ogunshola OO
    J Neuroinflammation; 2017 Oct; 14(1):202. PubMed ID: 29029628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diminished cytokine and chemokine expression in the central nervous system of GMF-deficient mice with experimental autoimmune encephalomyelitis.
    Zaheer A; Sahu SK; Wu Y; Zaheer A; Haas J; Lee K; Yang B
    Brain Res; 2007 May; 1144():239-47. PubMed ID: 17316572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.